Home/Filings/4/0001477286-10-000003
4//SEC Filing

Mayer Christine 4

Accession 0001477286-10-000003

CIK 0000885590other

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 4:09 PM ET

Size

12.4 KB

Accession

0001477286-10-000003

Insider Transaction Report

Form 4
Period: 2010-04-05
Mayer Christine
SVP,BTA Pharmaceuticals, Inc.
Transactions
  • Award

    Restricted Share Units

    2010-04-05+377,037 total
    From: 2013-02-17Exp: 2013-02-17Common Stock, no par value (37 underlying)
  • Award

    Restricted Share Units

    2010-04-05+356,630 total
    From: 2012-02-25Exp: 2012-02-25Common Stock, no par value (35 underlying)
  • Award

    Restricted Share Units

    2010-04-05+27250,886 total
    From: 2014-08-05Exp: 2014-08-05Common Stock, no par value (272 underlying)
  • Award

    Restricted Share Units

    2010-04-05+407,576 total
    From: 2011-03-12Exp: 2011-03-12Common Stock, no par value (40 underlying)
Footnotes (2)
  • [F1]Each Restricted Share Unit represents a contingent right to receive one share of Common Stock, no par value, of Biovail Corporation (the "Common Stock").
  • [F2]Represents dividend equivalents accrued on Restricted Share Units as a result of a dividend paid on the Common Stock on April 5, 2010.

Issuer

BIOVAIL CORP INTERNATIONAL

CIK 0000885590

Entity typeother

Related Parties

1
  • filerCIK 0001477286

Filing Metadata

Form type
4
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 4:09 PM ET
Size
12.4 KB